From the publishers of JADPRO

Gastrointestinal Stromal Tumor Resource Center

Advertisement
FROM THE EDITOR

Welcome to the Gastrointestinal Stromal Tumor (GIST) Resource Center! Here you’ll find the latest information, education, research, and other resources that focus on GIST and the advanced practitioner’s role in delivering high-quality care to our patients. I'm excited to provide this information to you and your colleagues and hope this site is helpful to your practice. We’ve kicked things off with a video discussion introducing GIST to our viewers, where we defined the disease and reviewed risk factors, common symptoms, associated conditions, and how to distinguish it from other GI conditions. 
 
Please send your questions and/or comments about this Resource Center to jadpro-editor@conexiant.com.

Regan Cronin Moran, MSN, RN, AGNP-BC, AOCNP® 
Duke Cancer Institute

News & Literature Highlights

International Journal of Clinical Oncology

Pooled safety analysis of pimitespib for the treatment of patients with advanced gastrointestinal stromal tumors

Cancer Research

Cancer-associated fibroblasts promote imatinib resistance in gastrointestinal stromal tumors through PGK1-mediated metabolic reprogramming

Journal of Cellular and Molecular Medicine

The mechanisms of imatinib resistance in gastrointestinal stromal tumours: Theoretical basis and therapeutic aspect

World Journal of Gastrointestinal Oncology

FGFR2 fusions as novel oncogenic drivers in gastrointestinal stromal tumors: Two case reports and review of literature

Surgical Case Reports

Neoadjuvant chemotherapy followed by laparoscopic and endoscopic cooperative surgery for locally advanced duodenal gastrointestinal stromal tumor: A case report

Pathology, Research and Practice

An interpretable machine learning framework for automated mitosis detection in gastrointestinal stromal tumors

European Journal of Clinical Pharmacology

Influence of genetic variants of imatinib on pharmacokinetics and recurrence-free survival in postoperative patients with gastrointestinal stromal tumor

Journal of the College of Physicians and Surgeons—Pakistan

Predictive significance of changes in haemoglobin level following imatinib treatment in patients with advanced gastrointestinal stromal tumour

Surgical Endoscopy

A novel prognostic system for locally advanced gastrointestinal stromal tumors after neoadjuvant imatinib therapy based on the metro-ticket paradigm: a retrospective dual-center study

World Journal of Gastrointestinal Oncology

Utility of inflammatory markers as predictors of recurrence in gastrointestinal stromal tumors: Insights from a nomogram-based approach

Advertisement
Advertisement